Results 31 to 40 of about 155,389 (150)

Shrimp genome sequence contains independent clusters of ancient and current Endogenous Viral Elements (EVE) of the parvovirus IHHNV

BMC Genomics, 2022
Background Shrimp have the ability to accommodate viruses in long term, persistent infections without signs of disease. Endogenous viral elements (EVE) play a role in this process probably via production of negative-sense Piwi-interacting RNA (piRNA ...
Suparat Taengchaiyaphum, Prapatsorn Wongkhaluang, Kanchana Sittikankaew, Nitsara Karoonuthaisiri, Timothy W. Flegel, Kallaya Sritunyalucksana   +5 more
doaj   +1 more source

Upregulation of CIP2A in estrogen depletion‐resistant breast cancer cells treated with low‐dose everolimus

FEBS Open Bio, 2020
Everolimus (EVE), an inhibitor of mammalian target of rapamycin, is an emerging second‐line therapeutic option for hormone therapy‐resistant breast cancers.
Eiji Nishio, Takanori Hayashi, Mao Akaza, Yukiko Hisatomi, Masahiro Hikichi, Takuma Fujii, Toshiaki Utsumi, Nobuhiro Harada, Yohei Shimono   +8 more
doaj   +1 more source

Building energy performance and housing market regimes: evidence from EU countries

Engineering Management in Production and Services
In assessing developments in the real estate market, the energy efficiency of buildings is increasingly considered important from an environmental and economic perspectives.
Linkevičius Dominykas, Neverauskienė Laima Okunevičiūtė   +1 more
doaj   +1 more source

Using Dynamic-Length Vector Operations to Efficiently Emulate Fixed-Length Vector Operations

Современные информационные технологии и IT-образование
Using vector registers can significantly enhance processor performance, especially in tasks that involve parallel data processing. To ensure code portability across different architectures, developers often use third-party libraries.
Konstantin Vladimirov, Ivan Tetyushkin
doaj   +1 more source

Is evolutionary science in conflict with Adam and Eve?

, 2021
Is evolutionary science in conflict with Adam and Eve? Christians throughout history have understood Adam and Eve as the “first man and woman” created in the image of God and placed in the Garden of Eden (Genesis 1:26-28, 2:4-25).
Daniel Ang, David Kwon, Jon Garvey, S. Joshua Swamidass   +3 more
core   +1 more source

Eve smiles on stage

, 1964
b&w, 8.3 x 11.5, "May 64" printed on front; "11 Eve Opera" handwritten on back; printed on Kodak ...
Hochstedler, Eli, 1942-1975
core   +1 more source

Ex-Vivo Uterine Environment (EVE) Therapy Induced Limited Fetal Inflammation in a Premature Lamb Model. [PDF]

PLoS ONE, 2015
Ex-vivo uterine environment (EVE) therapy uses an artificial placenta to provide gas exchange and nutrient delivery to a fetus submerged in an amniotic fluid bath.
Yuichiro Miura, Masatoshi Saito, Haruo Usuda, Eleanor Woodward, Judith Rittenschober-Böhm, Paranthaman S Kannan, Gabrielle C Musk, Tadashi Matsuda, John P Newnham, Matthew W Kemp   +9 more
doaj   +1 more source

Preparation and Electrochemical Performance of Zinc-Doped Copper Fluoride

Energies
To enhance the specific energy and rate performance of lithium primary batteries, the development of advanced cathode materials with superior electrochemical properties is essential. Fluorides, composed of light fluorine elements and multivalent cations,
Peng Dou, Pengcheng Liu, Zhiyong Yu
doaj   +1 more source

Everolimus Exposure as a Predictor of Toxicity in Renal Cell Cancer Patients in the Adjuvant Setting: Results of a Pharmacokinetic Analysis for SWOG S0931 (EVEREST), a Phase III Study (NCT01120249)

Kidney Cancer, 2019
Background: S0931 is assessing recurrence-free survival in renal cell carcinoma (RCC) patients randomized to receive everolimus (EVE) versus placebo for one year following nephrectomy.
Timothy W. Synold, Melissa Plets, Catherine M. Tangen, Elisabeth I. Heath, Ganesh S. Palapattu, Philip C. Mack, Mark N. Stein, Maxwell V. Meng, Primo Lara, Nicholas J. Vogelzang, Ian Murchie Thompson, Christopher W. Ryan   +11 more
doaj   +1 more source

Everolimus Nanoformulation in Biological Nanoparticles Increases Drug Responsiveness in Resistant and Low-Responsive Breast Cancer Cell Lines

Pharmaceutics, 2019
Everolimus (Eve) is an FDA approved drug that inhibits mammalian target of rapamycin (mTOR). It is employed in breast cancer treatment even if its responsiveness is controversial. In an attempt to increase Eve effectiveness, we have developed a novel Eve
Arianna Bonizzi, Marta Truffi, Marta Sevieri, Raffaele Allevi, Leopoldo Sitia, Roberta Ottria, Luca Sorrentino, Cristina Sottani, Sara Negri, Elena Grignani, Serena Mazzucchelli, Fabio Corsi   +11 more
doaj   +1 more source